Skip to main content
. 2024 Jul 8;17(6):603–617. doi: 10.1007/s40271-024-00702-w
This paper provides an overview of the role of treatment satisfaction in drug development, regulatory and HTA decision making.
The main goal is to call for more extensive use of fit-for-purpose PRO instruments to assess treatment satisfaction in all phases of drug development.